| 发明名称 |
VACCINE |
| 摘要 |
The present invention relates to a vaccine comprising at least two fragments of Proprotein convertase subtilisin/kexin type 9 (PCSK9), wherein said at least two fragments comprise at least 8 consecutive amino acid residues of amino acid residues 150 to 170 and/or 205 to 225 of PCSK9 (SEQ ID No. 9). |
| 申请公布号 |
US2015071951(A1) |
申请公布日期 |
2015.03.12 |
| 申请号 |
US201214344879 |
申请日期 |
2012.09.13 |
| 申请人 |
Brunner Sylvia;Galabova Gergana;Wanko Bettina;Windwarder Markus;Winsauer Gabriele;Staffler Guenther;Juno Claudia |
发明人 |
Brunner Sylvia;Galabova Gergana;Wanko Bettina;Windwarder Markus;Winsauer Gabriele;Staffler Guenther;Juno Claudia |
| 分类号 |
A61K39/00;A61K39/39;A61K39/385 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A vaccine, comprising at least two fragments of Proprotein convertase subtilisin/kexin type 9 (PCSK9), wherein a first fragment of said at least two fragments comprises at least 9 consecutive amino acid residues of amino acid residues 153 to 165 and a second fragment of said at least two fragments comprises at least 9 consecutive amino acid residues of amino acid residues 209 to 222 of PCSK9 (SEQ ID No. 9). |
| 地址 |
Vienna AT |
